Product Information
DOCUSATE CAL 240 MG SOFTGEL is a generic product labeled by Major Pharmaceuticals, priced at $0.0509 per EA under NDC 00904699740. Its NADAC has been published 252 times since Mar 24, 2021.
Strength
240 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904699740
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
1/22/2025
Active Ingredients
DOCUSATE CALCIUMApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
9/30/2019
Price Statistics
The NADAC for DOCUSATE CAL 240 MG SOFTGEL has been published 252 times since Mar 24, 2021, and over the history we have for it it has declined 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0509 per EA |
|---|---|
| All-time high | $0.0619 (Apr 13, 2022) |
| All-time low | $0.0458 (Jul 17, 2024) |
| 52-week high | $0.0509 |
| 52-week low | $0.0509 |
| Median price | $0.0546 |
| Average price | $0.0547 |
| Largest weekly change | +15.1% (Aug 21, 2024) |
| Weeks tracked | 252 |
| Tracking since | Mar 24, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
-6.1%
5Y
-9.3%
All
-7.2%
Last surveyed Jan 14, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Docusate calcium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOCUSATE CAL 240 MG SOFTGEL?
The current National Average Drug Acquisition Cost (NADAC) for DOCUSATE CAL 240 MG SOFTGEL, manufactured by Major Pharmaceuticals, is $0.0509 per EA (NDC 00904699740), effective Jan 14, 2026.
How has the price of DOCUSATE CAL 240 MG SOFTGEL changed over time?
Over the history we have for it, the NADAC for DOCUSATE CAL 240 MG SOFTGEL has declined 7.2%. It has been tracked across 252 weekly CMS publications since Mar 24, 2021.
What are the highest and lowest recorded NADAC prices for DOCUSATE CAL 240 MG SOFTGEL?
Since Mar 24, 2021, the NADAC for DOCUSATE CAL 240 MG SOFTGEL has ranged from a low of $0.0458 (Jul 17, 2024) to a high of $0.0619 (Apr 13, 2022), with a median of $0.0546 per EA.
Are there cheaper alternatives to DOCUSATE CAL 240 MG SOFTGEL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DOCUSATE CAL 240 MG SOFTGEL in a comparable dosage form, but none are currently priced below it.
Who manufactures DOCUSATE CAL 240 MG SOFTGEL?
DOCUSATE CAL 240 MG SOFTGEL (NDC 00904699740) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.